EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Echocardiographic features, antithrombotic therapy, and association with outcomes in patients with left ventricular thrombus after myocardial infarction: a single-center retrospective study

Mariya Maslarska-Martens, Celina Blank, Tian Li, Marius Wessinger, David Hesselbarth, Diona Gjermeni, Kilian Franke, Christian Valina, Nikolaus Jander, Sebastian Grundmann, Dennis Wolf, Dirk Westermann und 1 weitere

Clinical Research in Cardiology · 2026-12 · 115 (12) · 2241-2250

DOI: 10.1007/s00392-026-03020-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, online erschienen am 30.09.2026. Verfasst von Mariya Maslarska-Martens und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str…. Hauptthemen laut MEDLINE: Myocardial Infarction, Thrombosis, Echocardiography, Fibrinolytic Agents. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Freiburg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and aim Left ventricular thrombus (LVT) is a rare but threatening complication after acute myocardial infarction (MI). Guidelines recommend oral anticoagulation for at least 3–6 months. This retrospective, single-center cohort study describes the incidence of LVT, the antithrombotic regimen, and the association with LVT regression and clinical outcomes.

Methods

Patients admitted between January 1st, 2008, and December 31st, 2022, with MI were screened for the presence of LVT. Primary outcomes were the incidence of LVT, secular trends of oral anticoagulation prescription at discharge (direct oral anticoagulants vs Vitamin-K-antagonists), and change of LVT size or complete regression at follow-up examination. Secondary outcomes were all-cause death, embolic events associated with the LVT diagnosis, and bleeding events (BARC ≥ 2).

Results

A total of 19,964 patients admitted with MI between 2008 and 2022 were identified, of whom 166 (0.83%) had a confirmed LVT. Eighty-five patients were prescribed a VKA, 49 patients a DOAC, and 26 patients another form of anticoagulation. Transthoracic echocardiography follow-up was available for 120 patients, of whom 95 (79%) showed complete thrombus resolution. No statistically significant difference in complete thrombus resolution was detected between DOAC and VKA groups (87% vs. 79%; p = 0.42). Thirty-eight clinical events (bleeding, all-cause death, and embolic events) occurred within 12 months after LVT diagnosis without significant differences between DOAC and VKA.

Conclusion

DOAC use increased over time, with no statistically significant difference in early complete thrombus resolution or clinical events compared with VKA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionThrombosisEchocardiographyFibrinolytic AgentsAnticoagulantsHeart VentriclesHeart DiseasesHumansRetrospective StudiesFemaleMaleAgedIncidenceMiddle AgedFollow-Up StudiesAdministration, OralTreatment Outcome

Stichwörter der Autor:innen

Acute myocardial infarctionAnticoagulation therapyDirect oral anticoagulantsLeft ventricular thrombusVitamin k-antagonists

Substanzen

Fibrinolytic AgentsAnticoagulants

Autor:innen und Institutionen

  • Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
  • Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine Stanford, Stanford, CA, USA.
  • Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. christoph.olivier@uniklinik-freiburg.d…

Förderung

  • Universitätsklinikum Freiburg

Zitieren

APA

Maslarska-Martens, M., Blank, C., Li, T., Wessinger, M., Hesselbarth, D., Gjermeni, D., Franke, K., Valina, C., Jander, N., Grundmann, S., Wolf, D., Westermann, D., & Olivier, C. B. (2026). Echocardiographic features, antithrombotic therapy, and association with outcomes in patients with left ventricular thrombus after myocardial infarction: a single-center retrospective study. Clinical Research in Cardiology, 115(12), 2241-2250. https://doi.org/10.1007/s00392-026-03020-3

Vancouver

Maslarska-Martens M, Blank C, Li T, Wessinger M, Hesselbarth D, Gjermeni D, et al. Echocardiographic features, antithrombotic therapy, and association with outcomes in patients with left ventricular thrombus after myocardial infarction: a single-center retrospective study. Clinical Research in Cardiology. 2026;115(12):2241-2250. doi:10.1007/s00392-026-03020-3

BibTeX
@article{MaslarskaMartens2026,
  author = {Maslarska-Martens, Mariya and Blank, Celina and Li, Tian and Wessinger, Marius and Hesselbarth, David and Gjermeni, Diona and Franke, Kilian and Valina, Christian and Jander, Nikolaus and Grundmann, Sebastian and Wolf, Dennis and Westermann, Dirk and Olivier, Christoph B},
  title = {Echocardiographic features, antithrombotic therapy, and association with outcomes in patients with left ventricular thrombus after myocardial infarction: a single-center retrospective study},
  journal = {Clinical Research in Cardiology},
  year = {2026},
  volume = {115},
  number = {12},
  pages = {2241--2250},
  doi = {10.1007/s00392-026-03020-3}
}
Kostenlos starten →